Skip to content
Application 214525
- Type
- ANDA
- Sponsor
- LANNETT CO INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | MYCOPHENOLATE MOFETIL | MYCOPHENOLATE MOFETIL | SUSPENSION;ORAL | 200MG/ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 0527-5160 | Mycophenolate Mofetil | Mycophenolate Mofetil | Lannett Company, Inc. | ANDA | Current |
| 0527-5160 | Mycophenolate Mofetil | Mycophenolate Mofetil | Lannett Company, Inc. | ANDA | Current |
| 0527-5160 | Mycophenolate Mofetil | Mycophenolate Mofetil | Lannett Company, Inc. | ANDA | Current |
| 0527-5160 | Mycophenolate Mofetil | Mycophenolate Mofetil | Lannett Company, Inc. | ANDA | Current |
| 16714-345 | Mycophenolate Mofetil | Mycophenolate Mofetil | NorthStar RxLLC | ANDA | Current |
| 16714-345 | Mycophenolate Mofetil | Mycophenolate Mofetil | NorthStar RxLLC | ANDA | Current |
| 16714-345 | Mycophenolate Mofetil | Mycophenolate Mofetil | NorthStar RxLLC | ANDA | Current |
| 16714-345 | Mycophenolate Mofetil | Mycophenolate Mofetil | NorthStar RxLLC | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 76501 | ORIG | 2023-11-07 |